Hazel Hunt - 28 Sep 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Scientific Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Hazel Hunt
Issuer symbol
CORT
Transactions as of
28 Sep 2022
Transactions value $
-$677,122
Form type
4
Filing time
30 Sep 2022, 16:30:23 UTC
Previous filing
15 Feb 2023
Next filing
09 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $104K +50K +94.09% $2.08* 103K 28 Sep 2022 Direct
transaction CORT Common Stock Tax liability -$781K -30K -29.08% $26.04 73.1K 28 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -50K -100% $0.00* 0 28 Sep 2022 Common Stock 50K $2.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on January 30, 2023.
F2 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.